Most screenings end with a report. Ours ends with a conversation with a cancer specialist.
Risk assessment, on-site screening and specialist consultation, brought to your workplace, your community, or wherever your people are.
✓ A private one-on-one with an oncologist who has every result in hand
✓ A personalised risk report within 24–48 hours
✓ An anonymised group report for your organisation. Individual results go only to the individual.
Now enquiring for groups in Bengaluru and nearby cities.
Get the programme outline for your group
Tell us your group’s size, location and timeline, and we’ll suggest a programme that fits.
Cancer-specific, risk-based
Private one-on-one consultation
A routine health check or cancer screening? See the difference.
Most screenings hand you pieces. We hand you the whole picture, where every part is there because an oncologist would ask for it, and the specialist who can read it.
Led personally by Dr. Shalini Kamal Kumar
Consultant Radiation Oncologist · DNB (Radiation Oncology)
Intercept’s programmes are designed and led by Dr. Shalini Kamal Kumar, an oncologist with over six years in cancer care.
Over a decade
in healthcare
40 to 60
patients a day during three years of DNB training
Thousands
screened personally for oral, breast and cervical cancers
Every part of the screening, chosen and reviewed by an oncologist.
We know where to look before we meet you.
A specialist's eyes, not a checklist.
No contact. No radiation. No pain.
Numbers, read in context.
Every finding, read together by one specialist.
Get the programme outline for your group.
The right components and add-ons for your group, with programme details and pricing, shared once you enquire. Tell us your group’s size, location and timeline and we’ll take it from there.
Everything is in place before anyone walks in.
From the first questionnaire to the final report, Intercept runs every stage, so all you need to set is a date.
1
Tell us about your group
Its size, location and the timeline you have in mind.
2
We shape the programme around it
We recommend the right components and add-ons, and share details and pricing.
3
We set everything in motion
Your people receive clear communication and their risk assessment link, and the screening calendar is fixed.
Why early detection matters.
1 in 9
Indians likely to develop cancer by age 74
Fewer than 1 in 3
common cancers in India found at an early stage
🔒 Individual results go only to the individual. Organisations receive anonymised, group-level insights, never personal medical data.
Tell us about your group.
Tell us your group’s size, location and timeline, and we’ll suggest a programme that fits. Enquire for programme details and pricing.
Sources. 1 in 9: Sathishkumar K, et al. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian Journal of Medical Research. Fewer than 1 in 3: Mathur P, et al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Global Oncology, 2020.